Home » Topics » Regulatory » Patents

Patents
RSS

Recent KuDOS and Cancer Research Technology patent describes novel DNA-PK inhibitors

March 4, 2009

New Hsp90 inhibitors reported in recent patent from Merck KGaA

March 3, 2009

New EphB4 inhibitors reported in recent AstraZeneca patents

March 3, 2009

AstraZeneca claims novel JAK2 inhibitors with potential as anticancer agents

March 3, 2009

Novel VEGFR-3 (FLT4) inhibitors prepared and tested at sanofi-aventis

March 3, 2009

Abbott scientists describe new anticancer Sp1 inhibitors in recent patent

March 3, 2009

Abbott claims new Aurora kinase inhibitors as oncolytic agents

March 2, 2009

Sanofi-aventis presents novel PKB inhibitors for cancer

March 2, 2009

Novel PARP inhibitors under development at Abbott for the treatment of cancer

March 2, 2009

CrystaX scientists claim Hsp90 inhibitors and their use in cancer therapy

March 2, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...